| 1 |
Bauman NM, McCarter RJ, Guzzetta PC, Shin JJ, Oh AK, Preciado DA, et al. Propranolol vs prednisolone for symptomatic proliferating infantile hemangiomas: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg 2014;140:323-30.
DOI
|
| 2 |
Bagazgoitia L, Hernandez-Martin A, Torrelo A. Recurrence of infantile hemangiomas treated with propranolol. Pediatr Dermatol 2011;28:658-62.
DOI
|
| 3 |
Chang LC, Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 2008;122:360-7.
DOI
|
| 4 |
Leaute-Labreze C, Harper JI, Hoeger PH. Infantile haemangioma. Lancet 2017;390:85-94.
DOI
|
| 5 |
Garzon MC, Frieden IJ. Hemangiomas: when to worry. Pediatr Ann 2000;29:58-67.
DOI
|
| 6 |
Jung HL. Update on infantile hemangioma. Clin Exp Pediatrics 2021;64:559-72.
DOI
|
| 7 |
Drolet BA, Frommelt PC, Chamlin SL, Haggstrom A, Bauman NM, Chiu YE, et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics 2013;131:128-40.
DOI
|
| 8 |
Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-51.
DOI
|
| 9 |
Leaute-Labreze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med 2015;372:735-46.
DOI
|
webmaster
